Evidence map›Paper›PMID 29523637›Full record

ArticleG3 (Bethesda, Md.)2018

Robust ΦC31-Mediated Genome Engineering in

Roumen Voutev, Richard S Mann

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. CRISPR/Cas9-Mediated Knockout of the White Gene inInternational journal of molecular sciences · 2025
    Article
  2. Fluorescent labeling of genomic loci inCell reports methods · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roumen VoutevDepartments of Biochemistry and Molecular Biophysics and Systems Biology, Jerome L. Greene Science Center, Columbia University, New York, NY 10027 roumen.voutev@gmail.com rsm10@columbia.edu.ORCID 0000-0003-0066-4731
Richard S MannDepartments of Biochemistry and Molecular Biophysics and Systems Biology, Jerome L. Greene Science Center, Columbia University, New York, NY 10027 roumen.voutev@gmail.com rsm10@columbia.edu.ORCID 0000-0002-4749-2765

Funding

Interpreting and Deploying Genomic Information During Animal DevelopmentR35GM118336 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RICHARD S MANN · 2016 to 2026
$6.9M
NIGMS NIH HHS R35 GM118336
6 · The paper itself

Abstract

Effective genome engineering should lead to a desired locus change with minimal adverse impact to the genome itself. However, flanking loci with site-directed recombinase recognition sites, such as those of the phage ΦC31 integrase, allows for creation of platforms for cassette exchange and manipulation of genomic regions in an iterative manner, once specific loci have been targeted. Here we show that a genomic locus engineered with inverted minimal phage ΦC31 attP/attB sites can undergo efficient recombinase-mediated cassette exchange (RMCE) in the fruit fly

Indexed as

Genome, InsectAnimalsAttachment Sites, MicrobiologicalBacteriophagesDrosophila melanogasterGenetic EngineeringGreen Fluorescent ProteinsRecombinasesGreen Fluorescent ProteinsRecombinasesattB/attP sitescassette exchangeCRISPR/Cas9D. melanogastergenome editingGenome ReportΦC31 recombinase

Identifiers

PMID29523637
PMCPMC5940133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.